Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROGRESS: TIPS vs Anticoagulation for Portal Vein Thrombosis
NCT03422419Phase 3Withdrawn
- Sponsor
- Insel Gruppe
- Start
- Aug 2018
- Primary completion
- Oct 2020
01
Overview
Phase 3, randomised, open-label trial in portal vein thrombosis (PVT), sponsored by Insel Gruppe. Primary endpoint: Complete recanalization of the portal vein at 6 months. Planned start Aug 2018; status: withdrawn.
02
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT03422419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422419.